MedTrace Logo

Metagenomic and Metatranscriptomic Analysis of Clinical Plaque Samples

NCT05138978 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2021-12-01

No results posted yet for this study

Summary

The objective of this study is to determine the metagenomic and metatranscriptomic analysis of clinical samples.

Conditions

  • Plaque

Interventions

DRUG

Colgate Maximum Cavity Protection plus Sugar Acid Neutralizer

Toothpaste

DRUG

Colgate Cavity Protection

Toothpaste

Sponsors & Collaborators

  • Colgate Palmolive

    lead INDUSTRY

Principal Investigators

  • Luciana Rinaudi-Marron, DR · Colgate Palmolive

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-06
Primary Completion
2018-10-17
Completion
2018-10-17

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05138978 on ClinicalTrials.gov